Abstract:Introduction: Tuberculosis (TB) disease continues to be responsible for a high global burden with an estimated 10 million people falling ill each year and an estimated 1.45 million deaths. Widely carried out analyses to utilize routine data coming from this disease, and well-established in literature, have paid attention to time-to-event with sputum smear results being considered only at baseline or even ignored. Also, logistic regression models have been used to demonstrate importance of sputum smear results in patient outcomes. A feature presented by this disease, however, is that each individual patient is usually followed over a period of time with sputum smear results being documented at different points of the treatment curve. This provides both repeated measures and survival times, which may require a joint modeling approach. This study aimed to investigate the association between sputum smear results and the risk of experiencing unfavorable outcome among TB patients and dynamically predict survival probabilities. Method: A joint model for longitudinal and time-to-event data was used to analyze longitudinally measured smear test results with time to experiencing unfavorable outcome for TB patients. A generalized linear mixed-effects model was specified for the longitudinal submodel and cox proportional hazards model for the time-to-event submodel with baseline hazard approximated using penalized B-splines. The two submodels were then assumed to be related via the current value association structure. Bayesian approach was used to approximate parameter estimates using Markov Chain Monte Carlo (MCMC) algorithm. The obtained joint model was used to predict the subject's future risk of survival based on sputum smear results trajectories. Data were sourced from routinely collected TB data stored at National TB Program database. Results: The average baseline age was 35 (SD: 15). Female TB patients constituted 36.42%. Patients with previous history of TB treatment constituted 6.38% (event: 15.25%; no event: 5.29%). TB/HIV co-infection was at 31.23% (event: 47.87%; no event: 29.20%). The association parameter 1.03 (CI[1.03,1.04]) was found to be positive and significantly different from zero, interpreted as follows: The estimate of the association parameter α = 1.033 denoted the log hazard ratio for a unit increase in the log odds of having smear positive results. HIV status (negative) 0.47 (CI [0.46,49]) and history of TB treatment (previously treated) (2.52 CI [2.41,2.63]), sex (female) (0.82 CI [0.78,0.84]), and body mass index (BMI) categories (severe malnutrition being reference) were shown to be statistically significant. Conclusion: Sputum smear result is important in estimating the risk to unfavorable outcome among TB patients. Men, previously treated, TB/HIV co-infected and severely malnourished TB patients are at higher risk of unfavorable outcomes.

The prediction model for short-term recurrence after cured in initial-smear-positive pulmonary tuberculosis

Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China

Tuberculosis in China: A longitudinal predictive model of the general population and recommendations for achieving WHO goals.

Epidemiology of Recurrent Pulmonary Tuberculosis in Henan Province, China: Observational study (Preprint)

Effect of Different Interventions for Latent Tuberculosis Infections in China: a Model-Based Study

Recurrent Pulmonary Tuberculosis in China, 2005 to 2021

Tuberculosis Recurrence over a 7-Year Follow-Up Period in Successfully Treated Patients in a Routine Program Setting in China: a Prospective Longitudinal Study

How Do Smoking Status and Smoking Cessation Efforts Affect TB Recurrence after Successful Completion of Anti-TB Treatment? A Multicenter, Prospective Cohort Study with a 7-Year Follow-up in China.

Study on the Prediction of Smear Negative Pulmonary Tuberculosis with Classification Trees

Predictive machine learning models for anticipating loss to follow-up in tuberculosis patients throughout anti-TB treatment journey

Analysis of the Recurrence of New Smear Positive Tuberculosis Patients after DOTS from 1996 to 2005

Statistical methods for predicting tuberculosis incidence based on data from Guangxi, China

Establishment and Validation of a Predictive Model for Non-tuberculous Mycobacterial Infections in Acid-fast Bacilli Smear-positive Patients

Tuberculosis reinfection and relapse in eastern China: a prospective study using whole-genome sequencing

Investigation for prognosis of hospitalized patients with pulmonary tuberculosis and analysis for related factors

Short-course Regimen for Subsequent Treatment of Pulmonary Tuberculosis: A Prospective, Randomized, Controlled Multicenter Clinical Trial in China.

Risk factors analysis on anti-TB treatment outcomes of 757 primary pulmonary tuberculosis cases

Treatment and recurrence on re-treatment tuberculosis patients: a randomized clinical trial and 7-year perspective cohort study in China

Longitudinal-Survival Models for Case-Based Tuberculosis Progression

Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis

Survival Analysis on Tuberculosis Based on Cox Model at Bao'an District of Shenzhen City